Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults.
Saved in:
| Title: | Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults. |
|---|---|
| Authors: | Koram KA; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Walker KA; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Orizu B; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Marrero I; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Boyer J; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Yang S; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Broderick KE; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Kusi KA; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Kyei-Baafour E; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Ofori EA; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Pobee A; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Adu-Amankwah S; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Amoakoh-Coleman M; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Amoakoh HB; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.; Department of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, Netherlands., Abuaku B; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Badji E; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Ntiri M; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Quaye L; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana., Morrow MP; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Sylvester AJ; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Reuschel EL; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Gillespie E; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Liebowitz D; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States., Humeau LM; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Oct 24; Vol. 16, pp. 1658549. Date of Electronic Publication: 2025 Oct 24 (Print Publication: 2025). |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41208990 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Koram+KA%22">Koram KA</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Walker+KA%22">Walker KA</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Orizu+B%22">Orizu B</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Marrero+I%22">Marrero I</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Boyer+J%22">Boyer J</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Yang+S%22">Yang S</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Broderick+KE%22">Broderick KE</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Kusi+KA%22">Kusi KA</searchLink>; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Kyei-Baafour+E%22">Kyei-Baafour E</searchLink>; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Ofori+EA%22">Ofori EA</searchLink>; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Pobee+A%22">Pobee A</searchLink>; Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Adu-Amankwah+S%22">Adu-Amankwah S</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Amoakoh-Coleman+M%22">Amoakoh-Coleman M</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Amoakoh+HB%22">Amoakoh HB</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.; Department of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Abuaku+B%22">Abuaku B</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Badji+E%22">Badji E</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Ntiri+M%22">Ntiri M</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Quaye+L%22">Quaye L</searchLink>; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon-Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Morrow+MP%22">Morrow MP</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Sylvester+AJ%22">Sylvester AJ</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Reuschel+EL%22">Reuschel EL</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Gillespie+E%22">Gillespie E</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Liebowitz+D%22">Liebowitz D</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States.<br /><searchLink fieldCode="AU" term="%22Humeau+LM%22">Humeau LM</searchLink>; Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Oct 24; Vol. 16, pp. 1658549. <i>Date of Electronic Publication: </i>2025 Oct 24 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41208990 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1658549 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1658549 Titles: – TitleFull: Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Koram KA – PersonEntity: Name: NameFull: Walker KA – PersonEntity: Name: NameFull: Orizu B – PersonEntity: Name: NameFull: Marrero I – PersonEntity: Name: NameFull: Boyer J – PersonEntity: Name: NameFull: Yang S – PersonEntity: Name: NameFull: Broderick KE – PersonEntity: Name: NameFull: Kusi KA – PersonEntity: Name: NameFull: Kyei-Baafour E – PersonEntity: Name: NameFull: Ofori EA – PersonEntity: Name: NameFull: Pobee A – PersonEntity: Name: NameFull: Adu-Amankwah S – PersonEntity: Name: NameFull: Amoakoh-Coleman M – PersonEntity: Name: NameFull: Amoakoh HB – PersonEntity: Name: NameFull: Abuaku B – PersonEntity: Name: NameFull: Badji E – PersonEntity: Name: NameFull: Ntiri M – PersonEntity: Name: NameFull: Quaye L – PersonEntity: Name: NameFull: Morrow MP – PersonEntity: Name: NameFull: Sylvester AJ – PersonEntity: Name: NameFull: Reuschel EL – PersonEntity: Name: NameFull: Gillespie E – PersonEntity: Name: NameFull: Liebowitz D – PersonEntity: Name: NameFull: Humeau LM IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 10 Text: 2025 Oct 24 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |